Private Equity
Friendswood, Texas-based Castle Biosciences Inc, a dermatological cancer company, has raised $64 million for its IPO after pricing its 4 million shares at $16 per share. The stock began trading July 25, 2019 on the NASDAQ under the ticker symbol "CSTL." SVB Leerink and Baird are the lead underwriters. Castle Biosciences' pre-IPO backers included Industry Ventures, HealthQuest Capital and Mountain Group Partners.
2 min read · 25 July 2019
Athens, Georgia-based ArunA Bio Inc, a developer of neural exosomes for the treatment of neurodegenerative diseases, has raised $13 million in financing. The backers included Eshelman Ventures.
1 min read · 25 July 2019
Iowa-based VIDA Diagnostics Inc, which is focused on transforming pulmonary care through intelligence, has secured an undisclosed amount of funding. The investor was UnityPoint Health Ventures.
1 min read · 25 July 2019
Alpharetta, Georgia-based Ciox Health, a health tech company, has secured $30 million in funding. Merck Global Health Innovation Fund and New Mountain Capital led the financing.
1 min read · 25 July 2019
2 min read · 24 July 2019
Seattle-based SoundCommerce, a operations data platform provider, has named Meredith Han as chief operating officer. Her work background includes a tenure at Amazon.com where she helped launch the health and personal care business. SoundCommerce's backers included Defy Partners, Voyager Capital, Stage Venture Partners and Kick-Start Partners.
3 min read · 24 July 2019
FirstMark Capital has named Adam Nelson as a partner, according to an announcement on the New York City-based early-stage venture firm. Nelson's past roles including serving as an investing partner at Social Capital and head of revenue partnerships at Dropbox.
1 min read · 24 July 2019
What’s changing in corporate venture capital is not only the increased activity, but also a rethink of investment strategies.
3 min read · 24 July 2019
Menlo Park, California-based Tivic Health Systems, a bioelectronic medical device company that treats chronic conditions, has secured $8 million in funding. The backers included Sand Hill Angels, Astia Angels, Golden Seeds, HBS Angels, Sierra Angels, Lateral Capital and Skylight Investments.
1 min read · 24 July 2019
Woburn, Massachusetts-based Frequency Therapeutics, a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, has raised $62 million in Series C financing. Perceptive Advisors led the round.
1 min read · 24 July 2019
